S&P 500
(0.32%) 5 204.04 points
Dow Jones
(0.45%) 39 233 points
Nasdaq
(0.24%) 16 341 points
Oil
(0.29%) $79.22
Gas
(4.34%) $2.28
Gold
(0.90%) $2 343.10
Silver
(2.68%) $28.34
Platinum
(0.44%) $988.90
USD/EUR
(-0.22%) $0.928
USD/NOK
(-0.10%) $10.88
USD/GBP
(-0.11%) $0.799
USD/RUB
(0.89%) $92.56

Realtime updates for Eris Lifesciences Limited [ERIS.NS]

Exchange: NSE Sector: Healthcare Industry: Drug Manufacturers—Specialty & Generic
Upcoming Earnings Alert

5 days till quarter result
(bmo 2024-05-14)

Expected move: +/- 3.48%

Last Updated9 May 2024 @ 06:00

-2.89% INR 848.10

Live Chart Being Loaded With Signals

Commentary (9 May 2024 @ 06:00):

Eris Lifesciences Limited manufactures, markets, and distributes pharmaceutical products in India. It offers various branded formulations in various therapeutic areas, such as cardiovascular, anti–diabetes, anti-infective, antipyretics, vitamins/nutrients, gastroenterology, respiratory, gynecology, pediatrics, neurology, psychiatry, and pain/analgesics, as well as in-vitro fertilization, cosmetology, and dermatology...

Stats
Today's Volume 63 312.00
Average Volume 175 652
Market Cap 115.38B
EPS INR0 ( 2024-02-13 )
Next earnings date ( INR0 ) 2024-05-14
Last Dividend INR7.35 ( 2022-08-11 )
Next Dividend INR0 ( N/A )
P/E 29.95
ATR14 INR1.497 (0.17%)

Volume Correlation

Long: 0.03 (neutral)
Short: 0.92 (very strong)
Signal:(68.361) Expect same movement, but be aware

Eris Lifesciences Limited Correlation

10 Most Positive Correlations
NECCLTD.NS0.892
BINDALAGRO.NS0.889
ROSSARI.NS0.887
SETFNIF50.NS0.882
AXISNIFTY.NS0.881
INDIANHUME.NS0.881
KOTAKNIFTY.NS0.88
ICICINIFTY.NS0.879
LICNFNHGP.NS0.879
BSLNIFTY.NS0.878
10 Most Negative Correlations
SOMATEX.NS-0.88
JSL.NS-0.873
4THDIM.NS-0.859
KARDA.NS-0.839
BSELINFRA.NS-0.83
ISMTLTD.NS-0.819
GAIL.NS-0.817
KIRLFER.NS-0.815
FOSECOIND.NS-0.809
TARMAT.NS-0.804

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Eris Lifesciences Limited Correlation - Currency/Commodity

The country flag -0.13
( neutral )
The country flag -0.21
( neutral )
The country flag -0.07
( neutral )
The country flag -0.15
( neutral )
The country flag 0.46
( neutral )
The country flag -0.53
( weak negative )

Eris Lifesciences Limited Financials

Annual 2022
Revenue: INR16.62B
Gross Profit: INR13.09B (78.80 %)
EPS: INR28.10
FY 2022
Revenue: INR16.62B
Gross Profit: INR13.09B (78.80 %)
EPS: INR28.10
FY 2022
Revenue: INR13.26B
Gross Profit: INR10.65B (80.33 %)
EPS: INR29.89
FY 2021
Revenue: INR11.93B
Gross Profit: INR9.51B (79.72 %)
EPS: INR26.16

Financial Reports:

No articles found.

Eris Lifesciences Limited Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
INR7.35
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)

Eris Lifesciences Limited Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 3.44 - low (14.40%) | Divividend Growth Potential Score: 5.04 - Potential for dividend initiation, but uncertain (0.85%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend INR2.87 2020-03-19
Last Dividend INR7.35 2022-08-11
Next Dividend INR0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 4 --
Total Paid Out INR21.73 --
Avg. Dividend % Per Year 0.44% --
Score 1.99 --
Div. Sustainability Score 3.44
Div.Growth Potential Score 5.04
Div. Directional Score 4.24 --
Next Divdend (Est)
(2024-10-30)
INR0 Estimate 0.00 %
Dividend Stability
0.06 Very Bad
Dividend Score
1.99
Pay Frequency
Annually
Yearly Payout
Year Amount Yield
2020 INR8.37 1.69%
2021 INR6.01 1.02%
2022 INR7.35 0.96%
2023 INR0 0.00%
2024 INR0 0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
SHRADHA.NS Dividend Junior 2023-07-06 Sporadic 6 0.99%
MANORAMA.NS Dividend Junior 2023-09-11 Insufficient data to determine frequency 2 0.07%
GRAVITA.NS Dividend Junior 2023-09-04 Annually 14 0.72%
BAJAJHLDNG.NS Dividend Knight 2023-09-29 Annually 22 1.20%
POLYMED.NS Dividend Junior 2023-09-21 Annually 13 0.27%
JSL.NS Dividend Junior 2023-09-15 Sporadic 22 0.26%
DLF.NS Dividend Junior 2023-07-28 Annually 18 0.60%
AARON.NS Dividend Junior 2023-08-28 Sporadic 5 0.36%
SPAL.NS Dividend Junior 2023-09-15 Sporadic 8 0.44%
MONARCH.NS Dividend Junior 2023-09-14 Annually 3 0.20%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.2101.5005.808.70[0 - 0.5]
returnOnAssetsTTM01.20000[0 - 0.3]
returnOnEquityTTM0.1671.5009.2610.00[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM00.800-5.00-4.00[1 - 3]
quickRatioTTM00.800-4.71-3.76[0.8 - 2.5]
cashRatioTTM01.500-1.111-1.667[0.2 - 2]
debtRatioTTM0-1.50000[0 - 0.6]
interestCoverageTTM8.081.0008.128.12[3 - 30]
operatingCashFlowPerShareTTM19.152.003.627.23[0 - 30]
freeCashFlowPerShareTTM19.152.000.4240.847[0 - 20]
debtEquityRatioTTM0-1.50000[0 - 2.5]
grossProfitMarginTTM0.8181.00010.0010.00[0.2 - 0.8]
operatingProfitMarginTTM0.2661.0006.676.67[0.1 - 0.6]
cashFlowToDebtRatioTTM01.000-1.111-1.111[0.2 - 2]
assetTurnoverTTM00.800-3.33-2.67[0.5 - 2]
Total Score3.44

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM30.721.0007.000[1 - 100]
returnOnEquityTTM0.1672.509.5210.00[0.1 - 1.5]
freeCashFlowPerShareTTM19.152.003.620.847[0 - 30]
dividendYielPercentageTTM01.50000[0 - 0.4]
operatingCashFlowPerShareTTM19.152.003.627.23[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM2.151.50010.000[0.5 - 2]
operatingCashFlowSalesRatioTTM0.1421.0008.960[0.1 - 0.5]
Total Score5.04

Eris Lifesciences Limited

Eris Lifesciences Limited manufactures, markets, and distributes pharmaceutical products in India. It offers various branded formulations in various therapeutic areas, such as cardiovascular, anti–diabetes, anti-infective, antipyretics, vitamins/nutrients, gastroenterology, respiratory, gynecology, pediatrics, neurology, psychiatry, and pain/analgesics, as well as in-vitro fertilization, cosmetology, and dermatology. Eris Lifesciences Limited was incorporated in 2007 and is based in Ahmedabad, India.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators